GB2401879A - Absorbent material - Google Patents
Absorbent material Download PDFInfo
- Publication number
- GB2401879A GB2401879A GB0311448A GB0311448A GB2401879A GB 2401879 A GB2401879 A GB 2401879A GB 0311448 A GB0311448 A GB 0311448A GB 0311448 A GB0311448 A GB 0311448A GB 2401879 A GB2401879 A GB 2401879A
- Authority
- GB
- United Kingdom
- Prior art keywords
- weight
- fibres
- gelling
- alginate
- dressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000463 material Substances 0.000 title claims abstract description 63
- 239000002250 absorbent Substances 0.000 title claims abstract description 20
- 230000002745 absorbent Effects 0.000 title claims abstract description 19
- 229920001059 synthetic polymer Polymers 0.000 claims abstract description 3
- 206010052428 Wound Diseases 0.000 claims description 35
- 208000027418 Wounds and injury Diseases 0.000 claims description 35
- 235000010443 alginic acid Nutrition 0.000 claims description 34
- 229920000615 alginic acid Polymers 0.000 claims description 34
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 32
- 229940072056 alginate Drugs 0.000 claims description 32
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 14
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 14
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 14
- 229910052709 silver Inorganic materials 0.000 claims description 13
- 239000004332 silver Substances 0.000 claims description 13
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical group [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 12
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 12
- 239000000648 calcium alginate Substances 0.000 claims description 11
- 235000010410 calcium alginate Nutrition 0.000 claims description 11
- 229960002681 calcium alginate Drugs 0.000 claims description 11
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 239000004753 textile Substances 0.000 claims description 9
- 239000004677 Nylon Substances 0.000 claims description 7
- 229920001778 nylon Polymers 0.000 claims description 7
- 229920000297 Rayon Polymers 0.000 claims description 4
- 230000000845 anti-microbial effect Effects 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 239000000835 fiber Substances 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 238000009987 spinning Methods 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 239000012676 herbal extract Substances 0.000 claims description 3
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims description 3
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims description 2
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 2
- 230000003444 anaesthetic effect Effects 0.000 claims description 2
- 230000000202 analgesic effect Effects 0.000 claims description 2
- 230000000843 anti-fungal effect Effects 0.000 claims description 2
- 229940121375 antifungal agent Drugs 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 230000001684 chronic effect Effects 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- 239000005556 hormone Substances 0.000 claims description 2
- 229940088597 hormone Drugs 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920000570 polyether Polymers 0.000 claims description 2
- 239000002964 rayon Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 150000003431 steroids Chemical class 0.000 claims description 2
- 241001122767 Theaceae Species 0.000 claims 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 1
- 230000010261 cell growth Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000000243 solution Substances 0.000 description 8
- 239000010410 layer Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 239000006260 foam Substances 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 238000009960 carding Methods 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000000661 sodium alginate Substances 0.000 description 3
- 235000010413 sodium alginate Nutrition 0.000 description 3
- 229940005550 sodium alginate Drugs 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000296380 Laminaria hyperborea Species 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- -1 silver ions Chemical class 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A61F13/01042—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00217—Wound bandages not adhering to the wound
- A61F2013/00229—Wound bandages not adhering to the wound with alginate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00727—Plasters means for wound humidity control
- A61F2013/00731—Plasters means for wound humidity control with absorbing pads
- A61F2013/00744—Plasters means for wound humidity control with absorbing pads containing non-woven
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/0091—Plasters containing means with disinfecting or anaesthetics means, e.g. anti-mycrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00927—Plasters containing means with biological activity, e.g. enzymes for debriding wounds or others, collagen or growth factors
- A61F2013/00931—Plasters containing means with biological activity, e.g. enzymes for debriding wounds or others, collagen or growth factors chitin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00936—Plasters containing means metal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
Abstract
An absorbent material, e.g. for use as a wound dressing, comprises 55% to 95% by weight of gelling fibres and 5% to 45% by weight of non-gelling fibres. Most preferably the material comprises about 60% by weight of gelling fibres and 40% by weight of non-gelling fibres. The gelling fibres may, for example, be an alliginate. The non-gelling fibres may for example be a synthetic polymer.
Description
2401 879
ABSORBENT MATERIAL
The present invention relates to an absorbent material and more particularly to such a material comprised of gelling and non-gelling fibres. The invention relates even more particularly, but not exclusively, to a wound dressing comprised of such a material.
WO-A-9519795 (Bristol-Myers Squibb) discloses a wound dressing in the form of a sheet which is comprised of a mixture of gelling and non- gelling (textile) fibres. Such a dressing is considered to overcome disadvantages associated with dressings comprised solely of either gelling or non-gelling fibres. With regard to dressings comprised of gelling fibres, the incorporation of textile fibres reduces the overall cost of the dressing (since gel forming fibres are relatively expensive). With regard to dressings comprised of textile fibres (e.g. cotton gauze), a dressing comprised of a mixture of textile fibres and gelling fibres may be left in contact with the wound for longer.
The dressing specifically disclosed in WO-A-9519795 comprises from 50 /O to 95% by weight of textile fibres and from 5% to 50% by weight of gel forming fibres.
More preferred embodiments as disclosed in WO-A-9519795 comprise 75% to 90% (e.g. 80%) by weight of textile fibres and from 10% to 25% (e.g. 20%) by weight of gel forming fibres.
Thus the dressings specifically disclosed in WO-A-9519795 comprise a major proportion by weight of the textile (non-gelling) fibres and a minor proportion by weight of the gelling fibres. These relative amounts ensure moist wound healing to achieve an absorbency of at least 16g/g and intact removal of the dressing from the, , Some known dressings suffer from the disadvantage of a wet tensile strength À :.
of less than 1.2 N. À : À À e À en. :- À -
According to the present invention there is provided an absorbent material which comprises 55% to 95% by weight of gel forming fibres and 5% to 45% by weight of non-gelling fibres.
The invention is based on our unexpected finding that an absorbent material comprised of a major proportion by weight of gelling fibres and a minor proportion by weight of non-gelling fibres not only has good absorbency (as provided by the gelling fibres) but also has surprisingly high wet strength, typically greater than 4 N. in spite of the relatively high content of the gelling fibres. In fact, it is possible to achieve wet strengths which are higher than the dry strength values.
The absorbent material is preferably a non-woven material.
The absorbent material of the invention may be provided as a sheet or other physical form.
Absorbent materials in accordance with the invention are particularly useful as wound dressings. Such a dressing may be placed in direct contact with a wound (which may for example be an infected wound or a chronic wound) and are capable of absorbing relatively high levels of exudates. The dressing may be such that its wet integrity is such that the dressing may subsequently be removed in one piece without adhering to the wound. For use as a wound dressing, the absorbent material of the invention may, for example, be provided as a sheet or other form, e.g. a rope.
The invention is not however limited to use of the absorbent material as a À..
wound dressing and other applications are possible. Thus, for example, the material..
will find utility in tissue engineering, e.g. as a scaffold. À:. a.
Preferred materials in accordance with the invention comprise 55% to 65% by À . weight of the gelling fibres and 35% to 45% by weight of the nongelling fibres. A, À - particularly preferred embodiment comprises about 60% by weight of gelling fibres and about 40% by weight of non-gelling fibres.
Materials in accordance with the invention may have an absorbency of at least gig. More particularly, the absorbency may be at least 12 g/g, 14 gig or 16 g/g.
Yet more particularly, the absorbency may be at least 20 g/g or even higher. The absorbency of the higher absorbency materials (for example, those exhibiting an absorbency of greater than 18 g/lOOcm2) is a function of the specific composition of the material used.
Absorbency was measured using the following methods.
7.1 Conventional Absorbency 7.1.1 If felt or foam samples are greater than 5 x 5 cm, accurately cut 10 felt or foam samples using the 5 x 5 cm cutter (being careful not to stretch or distort the felt/foam). If testing rope samples, select and cut 10 rope samples, each approximately 4 cm in length. If testing the Spiral form of Alginate Dressing imagine to draw a line that joins the beginning of the spiral cut with the end point. With the scissors cut along this line the first 2 rings of the spiral dressing. The small spiral left is the sample to test.
7.1.2 Condition the sample in the conditioning chamber for a minimum of 16 hours. The conditioning chamber is kept at room temperature and contains a solution of Sodium Nitrite to maintain a constant humidity (66% humidity at 20 C). À. .
7.1.3 Place the empty petri dish on the balance and tare the balance.
À:::-: À.. . À À e. :* À.
7.1.4 Place one 5 x 5 cm sample of dressing (or one 4 cm rope/small spiral shaped sample) into the petri dish and record the weight to 3 decimal placed (We). Remove the petri dish and sample from the balance.
7.1.5 Either: Add solution A to the petri dish allowing a minimum ratio of solution A/rope weight of 100 and allow to stand for 30 minutes +/-1 minute, at approximately 37 C +/-3OC.
Or: Multiply We by 40 to the nearest 0.50g and add this weight of solution A to the petri dish and allow to stand for 30 minutes +/-1 minute, at approximately 37 C +/-3OC. NB in this latter case, the result will be BP absorption capacity.
7.1.6 Using forceps, suspend the sample by one corner for 30 seconds +/-1 second.
7.1.7 Weigh the sample (W2) 7.1.8 Repeat stages 7.2 - 7.8 above with the other 9 samples.
7.2 Sink Test Method 7.2.1 For the Sink Test method the samples do not need to be conditioned.
7.2.2 For 5 x 5 cm samples, eight samples should be used in each test. For x 10 cm sizes use two dressings, for all larger sizes of felt and all ropes, one piece should be used. For rollstock, cut a 30cm length of rope or two 10 x 10 cm pieces of felt. . a, . ..
7.2.3 Weigh the dry cage and record the weight as We : oe s 7.2.4 Felt samples should be folded if required and then rolled and placed into the testing 'cage' provided. The sample should be allowed to uncoil and fill the 'cage'.
7.2.5 Rope samples should be torn in two from end to end (i.e. forming two thin ropes of the same length as the original). Coil these two thin ropes and place into the sample cage provided, allowing the ropes to uncoil to fill the 'cage'.
7.2.6 Weigh the dry cage and sample W2.
7.2.7 Fill the 2000 ml beaker with solution A to a depth of lOcm.
7.2.8 Hold the 'cage' horizontally 1 cm above the liquid surface.
7.2.9 Drop the cage and wait for it to reach the bottom of the beaker.
7.2.10 Using your fingers, lift the cage out of the solution holding at one end so that it hangs at approximately 45 . Hold it in this way for precisely seconds allowing it to drain back into the beaker.
7.2.11 Weigh the wet sample and cage W3.
7.2.12 Repeat stages 7.2.1 to 7.2.1 1 a further two times.
7.2.13 Dry the cage after each test.
7.3 Results/Calculations.
To calculate absorbency in 'g/lOOcm2' (Not applicable to Spiral Alginate I Foam) : À. i' 1 -
g/100 cm2= (W2 - W') x 100/25, if the size is exactly 5 x 5 cm if not exactly 25 cm2, let area = x g/100 cm2= (W2 - We) x 100/x 7.3.2 Absorbency in g/g (applicable to spiral alginate foam dressing) Both the felt, foam and rope absorbency in gig can be calculated directly as: W2 - Wit Wl Calculate for all samples, then calculate XIO +/- 2SD 7.3.3 Absorbency in g/dressing If 5 x 5 cm dressing is tested, then W2 - We = Absorbency in g/dressing ActualAreacm For all other dressing sizes, (W2 - We) x 25 2 = Absorbency in g/dr Where, 25 = 5 x 5 cm. Calculate for each sample, then calculate XIO +/- 2SD.
The gelling fibres may comprise a water-absorbent natural or synthetic polymer that is capable of forming a gel on contact with water. The gel forming fibres will, for preference, be comprised of at least one polysaccharide which may be selected from the group consisting of alginates, cellulose (e.g. carboxymethyl cellulose, such as sodium carboxymethyl cellulose), chitosan, viscose and/or mixtures thereof. . . It is particularly preferred that the gelling fibres comprise at least a major.
proportion by weight, e.g. at least 80% by weight, of an alginate. The alginate is:.
preferably a calcium alginate. The alginate may comprise calcium alginate and sodium alginate in any ratio to suit a particular application. For example, in one preferred embodiment of the invention the calcium content expressed as a percentage of the total amount of calcium and sodium in the alginate is greater than 60% and may be greater than 90%.
Alginate dope contains only sodium alginate. The alginate dope is past through a spinneret in a coagulation bath containing calcium chloride solution.
Exchange of ions occurs to form calcium alginate. This results in calcium alginate fibre. By adding sodium chloride to the coagulation bath with calcium chloride in certain proportions the result is a mixture of sodium/calcium alginate fibres, comprising, for example, greater than 85% calcium expressed as a percentage of the total amount of calcium and sodium present in the alginate.
It is particularly preferred that the alginate has a G (guluronic) content of 65% to 75% by weight and correspondingly an M (mannuronic) content of 25% to 35% by weight. Preferably the alginate has a viscosity of between 30 to 100 cps in a 1% solution of the alginate in reverse osmosis deionised water.
A particularly suitable alginate may be derived from the seaweed Laminaria- Hyperborea which is harvested along the Norwegian coastline. Protanal LF 10/60 (available from FMC Biopymers, Norway) is an especially appropriate alginate.
It is particularly preferred that the gelling fibres comprised of a major proportion by weight of the alginate also incorporate carboxymethyl cellulose. For preference, such fibres comprise 80% to 90% by weight of the alginate and 10% to 20% by weight of the carboxymethyl cellulose. More preferably, such fibres comprise 84% to 86% (preferably about 85%) by weight of the alginate and 14% to 16% (preferably about 15% by weight of the carboxymethyl cellulose). Such fibres may be produced by the co-spinning technique disclosed in WO-A- 9610106. More particularly, a spinning dope comprised of an aqueous solution of the sodium salt of the alginate and sodium carboxymethyl cellulose may be extruded through a spinneret into a bath containing calcium ions to produce co-spun fibres, e.g. using the technique as described in Example 1 of WO-A-9610106.
The non-gelling fibres may be textile fibres and may for example be a polyamide (such as Nylon), polyester or polyether. Nylon fibres are particularly preferred.
The gelling and non-gelling fibres in the absorbent material may for example have a length of 2 cm to 20 cm and may be of 1 to 1000 denier. More preferably, the gelling and non-gelling fibres may have a length of 3 cm to 8 cm and may be of 1 to denier.
Absorbent materials in accordance with the invention in sheet form may, for example have a basis weight of 50 to 1000 gem, e.g. 100 to 200 gsm.
Preferred absorbent materials in accordance with the invention comprise a single layer, which is a mixture of the gelling and non-gelling fibres. Other constructions are however possible. For example, the absorbent material may comprise two layers, one being of the gelling fibres and the other being of the non- gelling fibres. A further possibility is a 3-layer structure, each of which comprises only one type of fibres. A still further possibility is a two of more layer structure in which one layer comprises one fibres type and a further layer comprises a mixture of fibres. À '
For use as wound dressing, it is preferred that the absorbent material.
incorporates a medicament that is released when in contact with wound exudates. The medicament may for example be selected from anaesthetic, analgesic, non-steroidal À..
anti-inflammatory drug (NSAID), steroid, hormone, antibiotic, antimicrobial, À , antifungal, metal salt, elemental metal, mineral, herbal extract (such as green tea....
extract), honey and combinations thereof. À.
It is particularly preferred that the medicament is an antimicrobial agent and is most preferably silver which is most preferably incorporated in or on the non-gelling fibres. It is particularly preferred that the silver is provided as a coating on the non- gelling fibres. Most preferably, the silver coating provides 20% to 30%, e.g. about 25%, by weight of the non-gelling fibres. The inventive material provides the advantages of not staining tissue with which it is in contact whilst enabling the release of silver ions at bactericidal levels. The specific composition of the inventive material and the manner in which the dressing is applied/removed enables accurate control of the administration of the antimicrobial agent to the wound.
Particularly preferred non-gelling fibres for use in the wound dressing in accordance with the invention comprise Nylon with a silver coating. The gelling fibres may comprise polyglytone or rayon.
A particularly preferred wound dressing in accordance with the invention has antimicrobial properties and comprises: (i) 55% to 65% (most preferably about 60%) by weight of gelling fibres which themselves comprise 80% to 90% by weight of calcium alginate and 10% to 20% by weight of carboxymethyl cellulose; and (ii) 35% to 45% (most preferably about 40%) by weight of silver-coated Nylon fibres. r r I À
The wound dressing preferably comprises a layer of fibres as defined for (i) . and (ii) above. À:e
The alginate fibres (i) are preferably as defined more specifically above. À . The Nylon fibres preferably comprise 20% to 30%, most preferably about ' ' 25%, by weight of silver. À Absorbent materials in accordance with the invention may be produced by conventional operations. Thus, for example, the materials may be produced by a carding operation. The fibres may initially be subjected to an 'opening procedure' to separate the fibres and reduced density and may then be passed to carding rollers to produce a carded web which may then be fed to a cross-lapper. If desired, the web may be subjected to a needling operation to achieve a thin layered, structured material.
The invention will be further illustrated with reference to the following non-
limiting Examples.
Example 1
This Example describes a wound dressing comprised of 40% by weight of nongelling fibres and 60% by weight of gelling fibres.
The gelling fibres were produced by co-spinning carboxymethyl cellulose and calcium alginate using the procedures disclosed in WO-A-9610106. The calcium alginate was Protanal LF 10/60 which has a G content in the range of 65% to 75% by weight. The CMC was Blanose_ (available from Aqualon (a division of Hercules Inc.)). The fibres comprise 15% by weight of the CMC and 85% by weight of the calcium alginate.
The fibres were of 1 to 5 denier and were cut to a length of 5 cm for the.
...DTD: purposes of producing the wound dressing. . The non-gelling fibres comprised 75% by weight of Nylon 6,6 coated with À.
25% by weight of silver. The fibres are commercially available under the brand name. À X-Static (Noble Fiber Technologies). ...
The non-gelling fibres were of 120 to 170 denier and had a length of 5 cm. À The gelling and non-gelling fibres were converted, by means of a carding operation, into a non-woven fibrous web. For this purpose, the gelling and non- gelling fibres were separately subjected to an 'opening procedure' to separate the fibres and reduce density. The 'open' fibres were then mixed together in the required weight ratio and fed to carding rollers operating at a constant speed to form a thin (e.g. greater than 1 mm) carded web. The carded web was fed into a cross- lapper where the mixed fibre web was folded into successive layers at constant speed to form a thicker, cross-laid web of thickness 5 to 15 cm. The web was then fed to a needling loom for packing. The needled web was wound and slit to produce a desired width of roll stock. In the case of 10 x 10 cm squares the machine achieve 5-6 rolls; in the case of rope the machine achieves 2 rolls.
The resulting material had a basis weight of between 100 to 170 gem with a mean basis weight of 135 gem.
Two types of wound dressing were produced using this procedure. For one material, the roll stock web had a width of 10 cm and was cut into 10 x 10 cm squares which were then sterilised and packaged according to standard techniques.
For the other type of wound dressing (the flat rope), the roll stock web had a width of 30.5 cm and was then cut into 2.5 cm sections which were individually wound into a blister pot which were then sterilised and packaged using conventional techniques.
The materials that had been subjected to packaging and sterilization were then.
tested for their properties. À .
Strips of the two types of dressing were tested for their dry-and wetstrength À , properties. Wet-strength was tested using the following procedure: .... À .
(i) For the lOxlO cm dressings, 20 mm strips were cut from a number of À À.
samples in each of the cross-and-machine-directions. For the 2.5 x 30.5 cm rope samples, 20 mm wide strips were cut in the cross and machine directions.
(ii) All strips were conditioned at a temperature of 20 C, 65% Relative I Humidity for 16 hours.
(iii) Each strip was then soaked in 40 times its own weight of Solution A (containing 142 millimoles of sodium ions and 2.5 millimoles calcium ion in distilled water) that had previously been warmed to 37 C and incubated at a temperature of 37 C for 30 minutes).
(iv) The strip was then suspended for 30 seconds.
(v) The wet strength was then measured using a Lloyd Instruments LRX (with 50N load cell and flat grips) and data logging station.
Dry strength was also measured using strips as detailed in (i) above and an apparatus as detailed in (v) above.
The above tests for dry and wet strength were repeated on several different batches of dressings.
The results for the strips cut from the 10 x 10 cm samples were as shown in
Table 1. .... À .
Table 1 À:.
BATCH NO. DRY STRENGTH WET STRENGTH ': 1 5.05 +/- 2.72 9.12 +/- 4.84....
5.83 +/- 4.60 6.88 +/- 3.90 ' ' 6.42 +/-3.59 11.65 +/- 6.16.. :.
Strength measured in N/sample width of 20 mm.
The results for the strips from the 2.5 x 30.5 samples are as shown in Table 2.
Table 2
BATCH NO. DRY STRENGTH WET STRENGTH 4 9.84 +/- 1.98 14.93 +/- 2.98 7.02 +/- 1.43 12.01 +/- 3.16 6 10.07 +/- 4.46 17.42 +/-3.6 Strength measured in N/sample width of 20 mm.
It can be seen from Tables 1 and 2 that, for all batches tested, the wet strength of the dressing was increased as compared to the dry strength. This is a particularly unexpected result in view of the relatively high amount of gelling fibres present in the dressings.
Example 2
A number of absorbent materials having various rations of gelling: nongelling; fibres were produced using the same fibres as described in Example 1. The absorbency of the materials was measured and the results are shown in Table 3.
Table 3
Ratio of gelling: non-gelling fibres Absorbency Absorbency g/g..e g/lOOcm2 À : 55:45 22 18...
60:40 25 20....
70:30 27 19 A:.
The mean basis weight of the samples tested was 135 gem using the Absorbancy test methods 7.1 and 7.2 as described above. À 1 I, À:
7 ' ' 7 À 7 A.
Claims (39)
1. An absorbent material comprising 55% to 95% by weight of gelling fibres and 5% to 45% by weight of non-gelling fibres.
2. A material as claimed in claim 1 comprising 55% to 65% by weight of gelling fibres and 35% to 45% by weight of non-gelling fibres.
3. A material as claimed in claim 2 comprising about 60% by weight of gelling fibres and about 40% by weight of non-gelling fibres.
4. A material as claimed in any one of claims I or 3 wherein the gelling fibres comprises at least one polysaccharide.
5. A material as claimed in claim 4 wherein the polysaccharide is selected from the group consisting of alginates, cellulose, chitosan, viscose and/or mixtures thereof.
6. A material as claimed in claim 5 wherein the polysaccharide comprises an alginate.
7. A material as claimed in claim 5 wherein the alginate has a G content of 65% to 75% by weight.
8. A material as claimed in claim 6 or 7 wherein the alginate comprises calcium alginate. . ..
9. A material as claimed in any one of claims 6 to 8 wherein the gelling fibre À..
comprises the alginate and carboxymethyl cellulose. :.
10. A material as claimed in claim 9 wherein the gelling fibre comprises 80% to À 90% by weight of the alginate and 10% to 20% by weight of the carboxymethyl À.
cellulose.
11. A material as claimed in claim 10 wherein the gelling fibres comprises 84% to 86% by weight of the alginate and 14% to 16% by weight of the carboxymethyl cellulose.
12. A material as claimed in claim 11 wherein the gelling fibres comprise about 85% by weight of the alginate and about 15% by weight of the carboxymethyl cellulose.
13. A material as claimed in any one of claims 9 to 12 wherein the fibres comprised of alginate and carboxymethyl cellulose have been produced by co- spinning the alginate and the carboxymethyl cellulose.
14. A material as claimed in any one of claims 1 to 3 wherein the gelling fibres comprise a synthetic polymer.
15. A material as claimed in claim 14 wherein the gelling fibres comprise polyglytone or rayon.
16. A material as claimed in any one of claims 1 to 15 wherein the nongelling fibres comprise textile fibres.
17. A material as claimed in any one of claims 1 to 16 wherein the nongelling fibres comprise a polyamide, polyester or polyether. . . .
18. A material as claimed in any one of claims 1 to 17 wherein the gelling and non-gelling fibres have a length of 2cm to 20cm. À
19. A material as claimed in any one of claims 1 to 18 wherein the gelling and the, non-gelling fibres are from 1 to 1000 denier. .
20. A material as claimed in any one of claims 1 to 19 in sheet form.
21. A material as claimed in claim 20 having a basis weight of 50 to 1000 gem.
22. A material as claimed in claim 20 or 21 having a thickness of 1 to 20 mm.
23. A material as claimed in any one of claims 1 to 22 which is a nonwoven material.
24. A material as claimed in any one of claims 1 to 23 having an absorbency of at least 10 g/g.
25. A material as claimed in claim 24 having an absorbency of at least 15 gig.
26. A wound dressing comprising a material as claimed in any one of claims 1 to 25.
27. A wound dressing as claimed in claim 26 incorporating a drug or other medically active component.
28. A wound dressing as claimed in claim 27 wherein the medically active component is selected from an anaesthetic, analgesic, non-steroidal antiinflammatory drug (NSAID), steroid, hormone, antibiotic, antimicrobial, antifungal, metal salt, elemental metal, mineral, herbal extract, honey and combinations thereof.
29. A wound dressing as claimed in claim 28 wherein the herbal extract is green; tea extract.
30. A wound dressing as claimed in claim 28 wherein the component is silver. I,, ' .,
31. A wound dressing as claimed in claim 30 wherein the silver is incorporated in the non-gelling fibres. I'
32. A dressing as claimed in claim 31 wherein the silver is provided as a coating on the non-gelling fibres.
33. An antimicrobial wound dressing comprising: (i) 55% to 65% by weight of gelling fibres which themselves comprise 80% to 90% by weight of calcium alginate and 10% to 20% by weight of carboxymethyl cellulose; and (ii) 35% to 45% by weight of silver-coated Nylon fibres.
34. A wound dressing as claimed in claim 31 which comprises: (i) About 60% by weight of said gelling fibres; and (ii) About 40% by weight of said silver-coated Nylon fibres.
35. A dressing as claimed in claim 33 or 34 wherein the alginate fibres have a G- content of 65% to 70% by weight.
36. A dressing as claimed in any one of claims 33 to 35 wherein the alginate fibres comprise 84% to 86% by weight of the alginate and 14% to 16% by weight of the carboxymethyl cellulose.
37. A method of treating a wound comprising applying to the wound a dressing as, ; claimed in any one of claims 26-36.
38. A method as claimed in claim 37 wherein the wound is an infected wound or a e e chronic wound. a a eeae À.a
39. A scaffold for cell growth comprised of a material as claimed in any one of a claims 1 to 24.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0311448A GB2401879A (en) | 2003-05-19 | 2003-05-19 | Absorbent material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0311448A GB2401879A (en) | 2003-05-19 | 2003-05-19 | Absorbent material |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0311448D0 GB0311448D0 (en) | 2003-06-25 |
GB2401879A true GB2401879A (en) | 2004-11-24 |
Family
ID=9958334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0311448A Withdrawn GB2401879A (en) | 2003-05-19 | 2003-05-19 | Absorbent material |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2401879A (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007085391A1 (en) * | 2006-01-30 | 2007-08-02 | Carl Freudenberg Kg | Layer and use of a layer as a dressing for direct wound contact |
WO2007098772A1 (en) * | 2006-03-03 | 2007-09-07 | Coloplast A/S | A wound dressing comprising an anti-inflammatory pain-killing agent and a complex of silver ion and a transitional element of group iv of the periodic system of elements |
WO2011018624A1 (en) * | 2009-08-13 | 2011-02-17 | Smith & Nephew Plc | Ultrasound couplant |
GB2474851A (en) * | 2009-10-27 | 2011-05-04 | Univ Bolton | Wound dressing comprising anti-microbial honey encapsulated within biocompatible and biodegradable fibre, and the fibre's production |
CN102133420A (en) * | 2011-03-02 | 2011-07-27 | 长沙海润生物技术有限公司 | Silver ion active carbon antimicrobial dressing and preparation method thereof |
WO2012092812A1 (en) * | 2011-01-05 | 2012-07-12 | 佛山市优特医疗科技有限公司 | Anti-bacterial, moisture absorptive and calcium ion donating wound dressing |
RU2468129C2 (en) * | 2010-12-30 | 2012-11-27 | Государственное образовательное учреждение высшего профессионального образования "Саратовский государственный университет им. Н.Г. Чернышевского" | Biopolymeric fibre, composition of forming solution for its obtaining, method of forming solution preparation, linen of biomedical purpose, biological bandage and method of wound treatment |
GB2504873A (en) * | 2011-11-01 | 2014-02-12 | Brightwake Ltd | Three-dimensional textile material for wound dressings |
CN104027832A (en) * | 2013-03-06 | 2014-09-10 | 特殊纤维及材料有限公司 | Absorbent Materials |
WO2015092314A1 (en) | 2013-12-20 | 2015-06-25 | Laboratoires Urgo | Composite material for filling cavity wounds |
WO2017161038A1 (en) * | 2016-03-18 | 2017-09-21 | Kci Usa, Inc. | Antimicrobial wound dressing |
WO2018055278A1 (en) | 2016-09-20 | 2018-03-29 | Urgo Recherche Innovation Et Developpement | Absorbent dressing comprising a water-disintegratable superabsorbent nonwoven |
US20180094369A1 (en) * | 2016-09-30 | 2018-04-05 | Advanced Medical Solutions Limited | Nonwoven fabric |
US10201456B2 (en) | 2011-03-31 | 2019-02-12 | Urgo Recherche Innovation Et Developpement | Absorbent cicatrization dressing and uses thereof for chronic wounds |
WO2023005036A1 (en) * | 2021-07-28 | 2023-02-02 | 江苏国望高科纤维有限公司 | Novel non-woven fabric wound dressing, preparation method therefor and application thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114984293B (en) * | 2022-06-29 | 2023-10-17 | 高亮 | Wound antibacterial healing-promoting dressing and preparation method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2208804A (en) * | 1987-08-19 | 1989-04-19 | Procter & Gamble | Absorbent structures with gelling agent and absorbent articles containing such structures |
US5061259A (en) * | 1987-08-19 | 1991-10-29 | The Procter & Gamble Company | Absorbent structures with gelling agent and absorbent articles containing such structures |
WO1995019795A1 (en) * | 1994-01-20 | 1995-07-27 | Bristol-Myers Squibb Company | Wound dressing |
WO1996010106A1 (en) * | 1994-09-29 | 1996-04-04 | Innovative Technologies Limited | Fibres |
US5843575A (en) * | 1994-02-17 | 1998-12-01 | The Procter & Gamble Company | Absorbent members comprising absorbent material having improved absorbent property |
US6099950A (en) * | 1994-02-17 | 2000-08-08 | The Procter & Gamble Company | Absorbent materials having improved absorbent property and methods for making the same |
EP1393757A1 (en) * | 2002-08-26 | 2004-03-03 | The Procter & Gamble Company | Absorbent cores for absorbent diapers having reduced thickness and improved liquid handling and retention performance and comprising a super absorbent polymer |
-
2003
- 2003-05-19 GB GB0311448A patent/GB2401879A/en not_active Withdrawn
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2208804A (en) * | 1987-08-19 | 1989-04-19 | Procter & Gamble | Absorbent structures with gelling agent and absorbent articles containing such structures |
US5061259A (en) * | 1987-08-19 | 1991-10-29 | The Procter & Gamble Company | Absorbent structures with gelling agent and absorbent articles containing such structures |
WO1995019795A1 (en) * | 1994-01-20 | 1995-07-27 | Bristol-Myers Squibb Company | Wound dressing |
US5843575A (en) * | 1994-02-17 | 1998-12-01 | The Procter & Gamble Company | Absorbent members comprising absorbent material having improved absorbent property |
US6099950A (en) * | 1994-02-17 | 2000-08-08 | The Procter & Gamble Company | Absorbent materials having improved absorbent property and methods for making the same |
WO1996010106A1 (en) * | 1994-09-29 | 1996-04-04 | Innovative Technologies Limited | Fibres |
EP1393757A1 (en) * | 2002-08-26 | 2004-03-03 | The Procter & Gamble Company | Absorbent cores for absorbent diapers having reduced thickness and improved liquid handling and retention performance and comprising a super absorbent polymer |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007085391A1 (en) * | 2006-01-30 | 2007-08-02 | Carl Freudenberg Kg | Layer and use of a layer as a dressing for direct wound contact |
WO2007098772A1 (en) * | 2006-03-03 | 2007-09-07 | Coloplast A/S | A wound dressing comprising an anti-inflammatory pain-killing agent and a complex of silver ion and a transitional element of group iv of the periodic system of elements |
WO2011018624A1 (en) * | 2009-08-13 | 2011-02-17 | Smith & Nephew Plc | Ultrasound couplant |
GB2474851A (en) * | 2009-10-27 | 2011-05-04 | Univ Bolton | Wound dressing comprising anti-microbial honey encapsulated within biocompatible and biodegradable fibre, and the fibre's production |
RU2468129C2 (en) * | 2010-12-30 | 2012-11-27 | Государственное образовательное учреждение высшего профессионального образования "Саратовский государственный университет им. Н.Г. Чернышевского" | Biopolymeric fibre, composition of forming solution for its obtaining, method of forming solution preparation, linen of biomedical purpose, biological bandage and method of wound treatment |
WO2012092812A1 (en) * | 2011-01-05 | 2012-07-12 | 佛山市优特医疗科技有限公司 | Anti-bacterial, moisture absorptive and calcium ion donating wound dressing |
CN102133420A (en) * | 2011-03-02 | 2011-07-27 | 长沙海润生物技术有限公司 | Silver ion active carbon antimicrobial dressing and preparation method thereof |
US10201456B2 (en) | 2011-03-31 | 2019-02-12 | Urgo Recherche Innovation Et Developpement | Absorbent cicatrization dressing and uses thereof for chronic wounds |
EP3296436A1 (en) * | 2011-11-01 | 2018-03-21 | Brightwake Limited | Wound dressings, and fabric useful therein |
GB2504873A (en) * | 2011-11-01 | 2014-02-12 | Brightwake Ltd | Three-dimensional textile material for wound dressings |
GB2496310B (en) * | 2011-11-01 | 2015-10-28 | Brightwake Ltd | Wound dressings, and yarn useful therein |
GB2504873B (en) * | 2011-11-01 | 2015-10-14 | Brightwake Ltd | Wound dressings, and yarn useful therein |
US9440001B2 (en) | 2013-03-06 | 2016-09-13 | Specialty Fibres and Materials Limited | Absorbent materials |
CN104027832A (en) * | 2013-03-06 | 2014-09-10 | 特殊纤维及材料有限公司 | Absorbent Materials |
GB2511528A (en) * | 2013-03-06 | 2014-09-10 | Speciality Fibres And Materials Ltd | Absorbent materials |
CN104027832B (en) * | 2013-03-06 | 2019-02-22 | 特殊纤维及材料有限公司 | Absorbing material |
WO2015092314A1 (en) | 2013-12-20 | 2015-06-25 | Laboratoires Urgo | Composite material for filling cavity wounds |
WO2017161038A1 (en) * | 2016-03-18 | 2017-09-21 | Kci Usa, Inc. | Antimicrobial wound dressing |
WO2018055278A1 (en) | 2016-09-20 | 2018-03-29 | Urgo Recherche Innovation Et Developpement | Absorbent dressing comprising a water-disintegratable superabsorbent nonwoven |
US20180094369A1 (en) * | 2016-09-30 | 2018-04-05 | Advanced Medical Solutions Limited | Nonwoven fabric |
US11459679B2 (en) * | 2016-09-30 | 2022-10-04 | Advanced Medical Solutions Limited | Nonwoven fabric |
WO2023005036A1 (en) * | 2021-07-28 | 2023-02-02 | 江苏国望高科纤维有限公司 | Novel non-woven fabric wound dressing, preparation method therefor and application thereof |
Also Published As
Publication number | Publication date |
---|---|
GB0311448D0 (en) | 2003-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2401879A (en) | Absorbent material | |
FI115608B (en) | wound dressing | |
KR100201747B1 (en) | Improved absorbency alginate fabric, use as wound and burn dressing and method for its preparation | |
EP3296436B1 (en) | Wound dressings, and fabric useful therein | |
US5197945A (en) | Alginate wound dressing of good integrity | |
AU2009254972B2 (en) | Compositions comprising honey and a super- absorbent material | |
EP1314410B1 (en) | Multi layered wound dressing | |
EP3087960A1 (en) | Wound dressing containing three-layer fabric and wound dressing manufacturing method | |
GB2524510A (en) | Wound dressing | |
US6458460B1 (en) | Wound dressing | |
US20080249453A1 (en) | Antimicrobial wound contact layer | |
US20050033213A1 (en) | Wound dressings | |
CN105007953A (en) | Wound dressing | |
EP2665452A1 (en) | Anti-microbial wound dressing and a method of producing the same | |
KR20180091145A (en) | Medical fibrous structure comprising chitosan and Manufacturing method of medical fibrous structure thereby | |
AU716252C (en) | Wound dressing | |
WO2021079126A1 (en) | Antimicrobial material | |
GB2380945A (en) | Multi-layered wound dressing | |
MXPA98008311A (en) | Composite fibers, wood bandage that includes such fibers and a method to manufacture lasmis | |
CZ76199A3 (en) | Wound dressing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |